• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

施尼茨勒综合征——慢性荨麻疹的罕见病因。病例报告。

Schnitzler syndrome - a rare cause of chronic urticaria. Case report.

作者信息

Moos Łukasz, Kułakowska Aleksandra, Szydłowska Dorota, Chodak Weronika, Brzoza Zenon

机构信息

Department of Internal Diseases, Allergology, Endocrinology and Gastroenterology, Institute of Medical Sciences, University of Opole, University Clinical Hospital, Al. Witosa 26, 45-401 Opole, Poland.

Students' scientific association "Alergos", Institute of Medical Sciences, University of Opole, University Clinical Hospital, Al. Witosa 26, 45-401 Opole, Poland.

出版信息

Oxf Med Case Reports. 2025 Jul 27;2025(7):omaf118. doi: 10.1093/omcr/omaf118. eCollection 2025 Jul.

DOI:10.1093/omcr/omaf118
PMID:40718535
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12296355/
Abstract

Schnitzler syndrome (SchS) is a very rare acquired systemic disease that has many similarities to hereditary autoinflammatory syndromes. The condition is characterized by the presence of monoclonal gammopathy and chronic urticaria. In this case report, a 64-year-old male patient with SchS was initially misdiagnosed with chronic spontaneous urticaria (CSU). The patient was treated with anakinra, showing good tolerance and no need for steroid therapy for 14 months. SchS is often underdiagnosed and presents symptoms such as prolonged urticarial wheals and systemic manifestations. The differential diagnoses include mastocytosis, urticarial vasculitis, and autoimmune diseases. The diagnostic criteria were elevated CRP levels, neutrophilic skin infiltration, leukocytosis, and abnormal bone remodeling on scintigraphy. Treatment options include highly effective interleukin-1 blockade therapies such as anakinra, canakinumab, and rilonacept. This case emphasizes the importance of a thorough differential diagnosis of chronic urticaria and encourages clinicians to participate in the SchS database for improved recognition and management.

摘要

施尼茨勒综合征(SchS)是一种非常罕见的获得性全身性疾病,与遗传性自身炎症综合征有许多相似之处。该病症的特征是存在单克隆丙种球蛋白病和慢性荨麻疹。在本病例报告中,一名64岁的施尼茨勒综合征男性患者最初被误诊为慢性自发性荨麻疹(CSU)。该患者接受了阿那白滞素治疗,显示出良好的耐受性,并且在14个月内无需使用类固醇疗法。施尼茨勒综合征常常诊断不足,表现出如持续性风团和全身症状等。鉴别诊断包括肥大细胞增多症、荨麻疹性血管炎和自身免疫性疾病。诊断标准为CRP水平升高、中性粒细胞皮肤浸润、白细胞增多以及骨闪烁显像显示骨重塑异常。治疗选择包括高效的白细胞介素-1阻断疗法,如阿那白滞素、卡那单抗和利罗那肽。本病例强调了对慢性荨麻疹进行全面鉴别诊断的重要性,并鼓励临床医生参与施尼茨勒综合征数据库,以提高识别和管理水平。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2531/12296355/da76bb4ad6cb/omaf118f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2531/12296355/6a002d144909/omaf118f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2531/12296355/bdd194327849/omaf118f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2531/12296355/b4d67bdbfa0f/omaf118f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2531/12296355/da76bb4ad6cb/omaf118f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2531/12296355/6a002d144909/omaf118f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2531/12296355/bdd194327849/omaf118f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2531/12296355/b4d67bdbfa0f/omaf118f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2531/12296355/da76bb4ad6cb/omaf118f4.jpg

相似文献

1
Schnitzler syndrome - a rare cause of chronic urticaria. Case report.施尼茨勒综合征——慢性荨麻疹的罕见病因。病例报告。
Oxf Med Case Reports. 2025 Jul 27;2025(7):omaf118. doi: 10.1093/omcr/omaf118. eCollection 2025 Jul.
2
Interventions for reducing inflammation in familial Mediterranean fever.家族性地中海热的抗炎干预措施。
Cochrane Database Syst Rev. 2022 Mar 29;3(3):CD010893. doi: 10.1002/14651858.CD010893.pub4.
3
Interleukin-1 inhibitors for acute gout.用于急性痛风的白细胞介素-1抑制剂
Cochrane Database Syst Rev. 2014 Sep 1;2014(9):CD009993. doi: 10.1002/14651858.CD009993.pub2.
4
Benralizumab does not elicit therapeutic effect in patients with chronic spontaneous urticaria: results from the phase IIb multinational randomized double-blind placebo-controlled ARROYO trial.贝那鲁肽在慢性自发性荨麻疹患者中没有疗效:来自 IIb 期多国随机双盲安慰剂对照 ARROYO 试验的结果。
Br J Dermatol. 2024 Jul 16;191(2):187-199. doi: 10.1093/bjd/ljae067.
5
Evaluating remibrutinib in the treatment of chronic spontaneous urticaria.评估瑞比鲁替尼治疗慢性自发性荨麻疹的效果。
Immunotherapy. 2025 May;17(7):479-484. doi: 10.1080/1750743X.2025.2510892. Epub 2025 Jun 2.
6
Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.在基层医疗机构或医院门诊环境中,如果患者出现以下症状和体征,可判断其是否患有 COVID-19。
Cochrane Database Syst Rev. 2022 May 20;5(5):CD013665. doi: 10.1002/14651858.CD013665.pub3.
7
Comorbidity and pathogenic links of chronic spontaneous urticaria and systemic lupus erythematosus--a systematic review.慢性自发性荨麻疹与系统性红斑狼疮的共病情况及致病关联——一项系统综述
Clin Exp Allergy. 2016 Feb;46(2):275-87. doi: 10.1111/cea.12673.
8
Systemic treatments for metastatic cutaneous melanoma.转移性皮肤黑色素瘤的全身治疗
Cochrane Database Syst Rev. 2018 Feb 6;2(2):CD011123. doi: 10.1002/14651858.CD011123.pub2.
9
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.慢性斑块状银屑病的全身药理学治疗:一项网状Meta分析。
Cochrane Database Syst Rev. 2020 Jan 9;1(1):CD011535. doi: 10.1002/14651858.CD011535.pub3.
10
Systemic Inflammatory Response Syndrome全身炎症反应综合征

本文引用的文献

1
Canakinumab leads to rapid reduction of neutrophilic inflammation and long-lasting response in Schnitzler syndrome.卡那单抗可使 Schnitzler 综合征患者的中性粒细胞炎症迅速减轻,并产生持久疗效。
Front Med (Lausanne). 2023 Mar 15;10:1050230. doi: 10.3389/fmed.2023.1050230. eCollection 2023.
2
Similarities and differences in autoinflammatory diseases with urticarial rash, cryopyrin-associated periodic syndrome and Schnitzler syndrome.荨麻疹性血管炎、冷吡啉相关周期性综合征和 Schnitzler 综合征的自身炎症性疾病的异同。
Allergol Int. 2023 Jul;72(3):385-393. doi: 10.1016/j.alit.2023.02.005. Epub 2023 Mar 10.
3
Dermatologic Manifestations of Noninflammasome-Mediated Autoinflammatory Diseases.
非炎性小体介导的自身炎症性疾病的皮肤表现
JID Innov. 2022 Dec 16;3(2):100176. doi: 10.1016/j.xjidi.2022.100176. eCollection 2023 Mar.
4
Summary of the current status of clinically diagnosed cases of Schnitzler syndrome in Japan.日本施尼茨勒综合征临床诊断病例的现状总结。
Allergol Int. 2023 Apr;72(2):297-305. doi: 10.1016/j.alit.2022.11.004. Epub 2022 Dec 2.
5
Absence of NLRP3 somatic mutations and VEXAS-related UBA1 mutations in a large cohort of patients with Schnitzler syndrome.一大群施尼茨勒综合征患者中无NLRP3体细胞突变和VEXAS相关的UBA1突变。
Allergy. 2022 Nov;77(11):3435-3436. doi: 10.1111/all.15411. Epub 2022 Jun 25.
6
Urticarial vasculitis: Clinical and laboratory findings with a particular emphasis on differential diagnosis.荨麻疹性血管炎:临床和实验室研究结果,特别强调鉴别诊断。
J Allergy Clin Immunol. 2022 Apr;149(4):1137-1149. doi: 10.1016/j.jaci.2022.02.007.
7
The international EAACI/GA²LEN/EuroGuiDerm/APAAACI guideline for the definition, classification, diagnosis, and management of urticaria.国际 EAACI/GA²LEN/EuroGuiDerm/APAAACI 荨麻疹定义、分类、诊断和管理指南。
Allergy. 2022 Mar;77(3):734-766. doi: 10.1111/all.15090. Epub 2021 Oct 20.
8
Pharmacological Inhibitors of the NLRP3 Inflammasome.NLRP3 炎性小体的药理学抑制剂。
Front Immunol. 2019 Oct 25;10:2538. doi: 10.3389/fimmu.2019.02538. eCollection 2019.
9
Neutrophilic urticarial dermatosis: A review.嗜中性粒细胞性荨麻疹性皮炎:综述
Ann Dermatol Venereol. 2018 Dec;145(12):735-740. doi: 10.1016/j.annder.2018.06.010. Epub 2018 Sep 14.
10
Mimickers of Urticaria: Urticarial Vasculitis and Autoinflammatory Diseases.荨麻疹的类症:荨麻疹性血管炎和自身炎症性疾病。
J Allergy Clin Immunol Pract. 2018 Jul-Aug;6(4):1162-1170. doi: 10.1016/j.jaip.2018.05.006. Epub 2018 Jun 2.